Skip to Main Content
Back to News

NASDAQ Earnings Preview: Recent $NDAQ Insider Trading, Hedge Fund Activity, and More

None

NASDAQ ($NDAQ) is expected to release its quarterly earnings data on Tuesday, October 21st before market open, per Finnhub. Analysts are expecting revenue of $1,321,024,582 and earnings of $0.86 per share.

You can see Quiver Quantitative's $NDAQ stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

NASDAQ Insider Trading Activity

NDAQ Insider Trades

NASDAQ insiders have traded $NDAQ stock on the open market 10 times in the past 6 months. Of those trades, 0 have been purchases and 10 have been sales.

Here’s a breakdown of recent trading of $NDAQ stock by insiders over the last 6 months:

  • BRADLEY J PETERSON (EVP, CIO) sold 11,508 shares for an estimated $1,022,715
  • MICHELLE LYNN DALY (SVP, Controller & PAO) sold 8,691 shares for an estimated $812,173
  • JEREMY SKULE (EVP, CSO) has made 0 purchases and 5 sales selling 8,421 shares for an estimated $758,471.
  • PC NELSON GRIGGS (Pres. Capital Access Platforms) has made 0 purchases and 2 sales selling 8,000 shares for an estimated $664,240.
  • CHARLENE T BEGLEY sold 3,000 shares for an estimated $289,800

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

NASDAQ Hedge Fund Activity

We have seen 548 institutional investors add shares of NASDAQ stock to their portfolio, and 382 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

NASDAQ Congressional Stock Trading

Members of Congress have traded $NDAQ stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $NDAQ stock by members of Congress over the last 6 months:

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

NASDAQ Analyst Ratings

Wall Street analysts have issued reports on $NDAQ in the last several months. We have seen 9 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • RBC Capital issued a "Outperform" rating on 07/25/2025
  • UBS issued a "Buy" rating on 07/25/2025
  • Keefe, Bruyette & Woods issued a "Outperform" rating on 07/25/2025
  • Deutsche Bank issued a "Buy" rating on 07/25/2025
  • Barclays issued a "Overweight" rating on 07/25/2025
  • Piper Sandler issued a "Overweight" rating on 07/15/2025
  • Raymond James issued a "Outperform" rating on 07/09/2025

To track analyst ratings and price targets for NASDAQ, check out Quiver Quantitative's $NDAQ forecast page.

NASDAQ Price Targets

Multiple analysts have issued price targets for $NDAQ recently. We have seen 10 analysts offer price targets for $NDAQ in the last 6 months, with a median target of $104.0.

Here are some recent targets:

  • Patrick O'Shaughnessy from Raymond James set a target price of $100.0 on 10/13/2025
  • Benjamin Budish from Barclays set a target price of $108.0 on 10/08/2025
  • Michael Cyprys from Morgan Stanley set a target price of $90.0 on 10/01/2025
  • Richard Repetto from Piper Sandler set a target price of $104.0 on 08/04/2025
  • Kyle Voigt from Keefe, Bruyette & Woods set a target price of $104.0 on 07/25/2025
  • Alex Kramm from UBS set a target price of $115.0 on 07/25/2025
  • Ashish Sabadra from RBC Capital set a target price of $108.0 on 07/25/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles